The global neuroendocrine carcinoma drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Neuroendocrine carcinomas usually form solid tumors and they are the most common type of cancer as neuroendocrine carcinomas carcinoma include prostate cancer, breast cancer, lung cancer, and colorectal cancer.The market is driven by growing awareness of […]
